Medivation, Inc.
(Public, NASDAQ:MDVN) Watch this stockFind more results for
MDVN
Advertisement
Events
Jan 11, 2010
JPMorgan Healthcare Conference
|
More events from AOL Finance »
|
Key stats and ratios
| Q3 (Sep '09) | 2008 | |
| Net profit margin | -85.51% | -496.58% |
| Operating margin | -68.68% | -510.27% |
| EBITD margin | - | -508.74% |
| Return on average assets | -23.37% | -45.45% |
| Return on average equity | -110.91% | -280.93% |
| Employees | 59 | - |
Address
201 Spear Street 3rd Floor
San Francisco, CA 94105
United States - Map
+1-415-5433470 (Phone)
+1-415-5433113 (Fax)
San Francisco, CA 94105
United States - Map
+1-415-5433470 (Phone)
+1-415-5433113 (Fax)
Website links
Company website:
http://www.medivation.com/
http://www.medivation.com/
External links
Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Medivation, Inc. discussions
View all discussions »Description
Medivation, Inc. is a biopharmaceutical company with small molecule drugs in clinical development to treat three medical needs: Alzheimer’s disease, Huntington’s disease and castration-resistant prostate cancer. The Company has formed separate subsidiaries to hold the product candidates it is developing. The Company’s subsidiary Medivation Neurology, Inc. holds its Dimebon technology, and its subsidiary Medivation Prostate Therapeutics, Inc. holds its MDV300 series technology.
Officers and directors
| Kim D. Blickenstaff | Chairman of the Board | |
| David T. Hung M.D. | President, Chief Executive Officer, Director | |
| C. Patrick Machado J.D. | Chief Financial Officer, Chief Business Officer | |
| Lynn Seely M.D. | Senior Vice President, Chief Medical Officer | |
| Karen Reeves | Senior Vice President - Clinical Development | |
| Hank Mansbach M.D. | Vice President - Medical Affairs | |
| Bryan Selby | Vice President - Biometrics | |
| Vandana Date | Vice President - Intellectual Property | |
| Rohan Palekar | Chief Commercial Officer | |
| Daniel D. Adams | Director |